• Hospital wide
  • Intensive care unit
  • SARS-CoV-2
  • Post-COVID-19
  • Pharmacological intervention
  • Immnunomodulator
  • Antineoplastic agent
  • Imatinib
  • Infliximab
  • Monoclonal antibodies